NMR solution structure and receptor peptide binding of the CC chemokine eotaxin-2

被引:55
作者
Mayer, KL [1 ]
Stone, MJ [1 ]
机构
[1] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA
关键词
D O I
10.1021/bi000523j
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human CC chemokine eotaxin-2 is a specific agonist for the chemokine receptor CCR3 and may play a role in the recruitment of eosinophils in allergic diseases and parasitic infections. We report the solution structure of eotaxin-2 determined using heteronuclear and triple resonance NMR methods. A family of 20 structures was calculated by hybrid distance geometry-simulated annealing from 854 NOE distance restraints, 48 dihedral angle restraints, and 12 hydrogen bond restraints. The structure of eotaxin-2 (73 amino acid residues) consists of a helical turn (residues 17-20) followed by a 3-stranded antiparallel beta-sheet (residues 22-26, 37-41, and 44-49) and an alpha-helix (residues 54-66). The N-loop (residues 9-16) is packed against both the sheet and the helix with the two conserved disulfide bonds tethering the N-terminal/N-loop region to the beta-sheet. The average backbone and heavy atom rmsd values of the 20 structures (residues 7-66) are 0.52 and 1.13 Angstrom, respectively. A linear peptide corresponding to the N-terminal region of CCR3 binds to eotaxin-2, inducing concentration-dependent chemical shift changes or line broadening of many residues. The distribution of these residues suggests that the peptide binds into an extended groove located at the interface between the N-loop and the beta 2-beta 3 hairpin. The receptor peptide may also interact with the N-terminus of the chemokine and part of the alpha-helix. Comparison of the eotaxin-2 structure with those of related chemokines indicates several structural features that may contribute to receptor specificity.
引用
收藏
页码:8382 / 8395
页数:14
相关论文
共 86 条
[61]   NEUTROPHIL ACTIVATION BY MONOMERIC INTERLEUKIN-8 [J].
RAJARATHNAM, K ;
SYKES, BD ;
KAY, CM ;
DEWALD, B ;
GEISER, T ;
BAGGIOLINI, M ;
CLARKLEWIS, I .
SCIENCE, 1994, 264 (5155) :90-92
[62]  
RALSTON G, 1993, INTRO ANAL ULTRACENT
[63]  
Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3
[64]   Chemokines [J].
Rollins, BJ .
BLOOD, 1997, 90 (03) :909-928
[65]   Discovering high-affinity ligands for proteins: SAR by NMR [J].
Shuker, SB ;
Hajduk, PJ ;
Meadows, RP ;
Fesik, SW .
SCIENCE, 1996, 274 (5292) :1531-1534
[66]   Structure of a CXC chemokine-receptor fragment in complex with interleukin-8 [J].
Skelton, NJ ;
Quan, C ;
Reilly, D ;
Lowman, H .
STRUCTURE, 1999, 7 (02) :157-168
[67]   Solution structure of the human CC chemokine 2:: A monomeric representative of the CC chemokine subtype [J].
Sticht, H ;
Escher, SE ;
Schweimer, K ;
Forssmann, WG ;
Rösch, P ;
Adermann, K .
BIOCHEMISTRY, 1999, 38 (19) :5995-6002
[68]  
Stone MJ, 2000, CHEMOKINES IN ALLERGIC DISEASE, P67
[69]  
Struyf S, 1999, J IMMUNOL, V162, P4903
[70]  
STUDIER FW, 1990, METHOD ENZYMOL, V185, P60